Spreadsheet: 4341e9d9-ec86-424f-a11c-46adcb3f00ad
Sheet: tab18

 |  | Estimated Vaccination Coverage*,† with Selected Vaccines Among Adolescents 13-17 Years of Age§ by Poverty Level¶ and Race/Ethnicity**  -- National Immunization Survey-Teen, United States, 2010
Vaccines |  | Total | White only,                        non-Hispanic | Black only,                         non-Hispanic | Hispanic | American Indian or [NAME] only, non-Hispanic | Asian only, non-Hispanic
 |  | % (95% C.I.) | % (95% C.I.) | % (95% C.I.) | % (95% C.I.) | % (95% C.I.) | % (95% C.I.)
≥2 MMR†† | US National | 90.5 (89.6-91.3) | 91.6 (90.7-92.4) | 90.8 (88.7-92.6) | 86.2 (82.9-88.9) | 92.1 (86.2-95.6) | 93.8 (90.8-95.9)
 | At or Above Poverty | 91.1 (90.3-92.0) | 91.7 (90.8-92.6) | 90.2 (87.2-92.6) | 88.1 (84.3-91.1) | 90.0 (80.8-95.1) | 94.1 (90.8-96.3)
 | Below Poverty | 87.8 (84.9-90.1) | 90.4 (87.3-92.8) | 92.1 (89.0-94.4) | 83.5 (77.0-88.4) | 93.9 (84.3-97.8) | 90.4 (76.8-96.4)
 | Unknown Poverty | 90.7 (86.5-93.7) | 91.3 (86.1-94.7) | 90.1 (76.5-96.2) | 87.0 (71.9-94.6) | NA | 95.4 (78.2-99.2)
[NAME] 3 [NAME] | US National | 91.6 (90.8-92.4) | 92.7 (91.8-93.4) | 90.9 (88.8-92.6) | 88.9 (85.8-91.3) | 92.8 (87.2-96.1) | 93.6 (90.2-95.8)
 | At or Above Poverty | 92.4 (91.6-93.1) | 92.8 (91.9-93.6) | 91.3 (88.8-93.4) | 91.0 (88.1-93.3) | 91.6 (82.6-96.2) | 95.0 (91.8-96.9)
 | Below Poverty | 89.0 (86.2-91.3) | 90.8 (87.0-93.6) | 90.0 (85.7-93.1) | 87.8 (81.6-92.1) | 93.6 (84.6-97.5) | 83.3 (66.5-92.6)
 | Unknown Poverty | 90.3 (84.8-93.9) | 93.6 (88.5-96.5) | 91.8 (79.8-96.9) | 76.6 (55.6-89.5) | NA | 95.4 (78.2-99.2)
[NAME] 1 Var¶¶ | US National | 90.5 (89.4-91.5) | 91.2 (90.1-92.1) | 89.2 (85.8-91.9) | 90.6 (86.7-93.4) | 88.0 (75.2-94.6) | 89.7 (81.4-94.5)
 | At or Above Poverty | 91.2 (90.2-92.2) | 91.7 (90.6-92.7) | 89.5 (84.8-92.9) | 92.1 (89.0-94.4) | 87.7 (71.0-95.4) | 89.3 (78.8-94.9)
 | Below Poverty | 86.7 (82.7-89.9) | 85.6 (80.2-89.8) | 87.0 (80.5-91.6) | 88.1 (78.8-93.6) | 85.4 (57.6-96.2) | 86.4 (64.8-95.6)
 | Unknown Poverty | 93.6 (90.0-96.0) | 91.6 (86.2-95.0) | 98.5 (94.5-99.6) | 93.9 (78.2-98.5) | NA | NA
[NAME]*** | US National | 58.1 (56.4-59.8) | 59.2 (57.3-61.0) | 55.3 (50.2-60.3) | 56.2 (51.0-61.2) | 58.7 (43.9-72.1) | 62.9 (52.7-72.2)
 | At or Above Poverty | 58.9 (57.1-60.7) | 60.4 (58.5-62.3) | 51.8 (45.9-57.6) | 56.7 (50.4-62.7) | 63.6 (46.3-77.9) | 63.2 (50.7-74.1)
 | Below Poverty | 53.8 (48.7-58.7) | 42.9 (36.1-49.9) | 60.3 (50.8-69.0) | 55.8 (46.6-64.5) | 63.1 (38.0-82.7) | 54.9 (35.5-73.0)
 | Unknown Poverty | 61.9 (53.4-69.8) | 64.8 (55.1-73.4) | 62.0 (37.5-81.6) | 54.0 (30.5-75.8) | NA | NA
[NAME] 1 Td or Tdap††† | US National | 81.2 (80.2-82.2) | 80.9 (79.8-81.9) | 80.5 (77.8-83.0) | 82.4 (79.4-85.1) | 82.7 (74.9-88.4) | 85.8 (77.9-91.2)
 | At or Above Poverty | 82.2 (81.2-83.2) | 82.1 (81.0-83.2) | 80.1 (76.4-83.4) | 85.0 (81.7-87.7) | 83.7 (73.8-90.4) | 82.8 (72.7-89.7)
 | Below Poverty | 76.8 (73.7-79.6) | 70.2 (64.8-75.0) | 80.1 (75.5-84.0) | 78.9 (72.7-83.9) | 80.4 (65.0-90.0) | 90.7 (76.1-96.8)
 | Unknown Poverty | 82.8 (78.3-86.6) | 79.6 (72.9-85.0) | 86.3 (74.3-93.2) | 83.9 (74.2-90.4) | NA | 97.9 (93.5-99.4)
[NAME] 1 Tdap§§§ | US National | 68.7 (67.5-69.8) | 68.6 (67.3-69.9) | 66.9 (63.5-70.2) | 69.6 (66.1-73.0) | 68.4 (58.4-76.9) | 74.4 (66.2-81.2)
 | At or Above Poverty | 69.5 (68.3-70.7) | 69.9 (68.6-71.2) | 66.0 (61.6-70.0) | 70.6 (66.3-74.6) | 68.7 (55.7-79.3) | 71.6 (61.8-79.7)
 | Below Poverty | 64.7 (61.3-68.0) | 57.5 (52.2-62.6) | 68.1 (61.9-73.6) | 67.4 (60.9-73.3) | 70.4 (53.0-83.4) | 80.9 (66.8-89.9)
 | Unknown Poverty | 70.8 (65.5-75.5) | 67.3 (60.5-73.5) | 70.9 (55.6-82.6) | 75.4 (63.6-84.4) | NA | 84.2 (54.8-95.9)
[NAME] 1 MenACWY¶¶¶ | US National | 62.7 (61.5-63.9) | 61.2 (59.8-62.5) | 63.4 (59.8-66.8) | 66.1 (62.5-69.6) | 62.4 (52.1-71.6) | 71.6 (62.2-79.4)
 | At or Above Poverty | 62.9 (61.6-64.2) | 62.5 (61.1-63.9) | 61.4 (56.9-65.8) | 64.4 (59.7-68.8) | 67.5 (55.1-77.9) | 74.3 (64.7-82.1)
 | Below Poverty | 62.0 (58.5-65.2) | 50.3 (45.1-55.4) | 66.5 (60.1-72.3) | 67.4 (61.1-73.1) | 60.8 (44.4-75.1) | 77.1 (60.8-88.0)
 | Unknown Poverty | 62.3 (56.3-68.0) | 59.4 (52.3-66.1) | 67.0 (51.2-79.7) | 73.4 (59.3-84.0) | NA | NA
[NAME] 1 HPV**** | US National | 48.7 (46.9-50.5) | 45.8 (43.8-47.9) | 48.9 (43.8-54.1) | 56.2 (50.6-61.6) | 64.8 (46.6-79.5) | 50.1 (38.2-61.9)
 | At or Above Poverty | 47.7 (45.7-49.6) | 46.6 (44.5-48.7) | 44.5 (38.2-50.9) | 53.5 (46.6-60.3) | 47.8 (26.5-70.0) | 49.0 (35.4-62.7)
 | Below Poverty | 51.8 (46.8-56.8) | 39.4 (32.7-46.6) | 55.7 (47.0-64.1) | 57.9 (48.2-67.0) | 87.3 (75.4-93.9) | 67.7 (42.4-85.6)
 | Unknown Poverty | 52.1 (44.2-59.8) | 45.5 (36.8-54.5) | 61.9 (39.5-80.2) | 66.9 (47.3-82.0) | NA | NA
[NAME] 3 HPV | US National | 32.0 (30.3-33.6) | 32.4 (30.6-34.2) | 30.2 (25.5-35.4) | 29.5 (25.0-34.4) | 40.5 (26.7-56.0) | 39.8 (28.3-52.5)
 | At or Above Poverty | 32.9 (31.1-34.7) | 32.8 (30.9-34.8) | 28.6 (23.0-35.0) | 32.9 (26.8-39.5) | 33.2 (17.4-53.9) | 40.5 (27.3-55.3)
 | Below Poverty | 28.2 (24.2-32.4) | 25.7 (20.4-31.7) | 31.6 (23.9-40.4) | 27.1 (20.2-35.4) | 57.4 (36.3-76.1) | NA
 | Unknown Poverty | 33.0 (25.8-41.0) | 37.7 (29.4-46.8) | NA | NA | NA | NA
HPV 3 dose series completion†††† | US National | 69.6 (66.8-72.2) | 74.7 (71.6-77.5) | 65.4 (57.5-72.5) | 56.1 (48.5-63.5) | 64.0 (45.6-79.1) | 86.0 (75.4-92.5)
 | At or Above Poverty | 73.2 (70.3-76.0) | 74.7 (71.3-77.7) | 68.6 (58.7-77.0) | 65.0 (55.0-73.9) | 73.0 (52.2-87.0) | 87.7 (76.8-93.9)
 | Below Poverty | 57.3 (50.1-64.2) | 69.4 (58.6-78.4) | 59.4 (45.7-71.9) | 49.3 (37.4-61.2) | 66.3 (42.0-84.3) | NA
 | Unknown Poverty | 68.1 (56.2-78.1) | 83.2 (72.9-90.1) | NA | NA | NA | NA
 |  | *  Estimate presented as point estimate (%) ± 95% confidence interval (CI). Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.588.
 |  | † Estimates with confidence intervals >20 may not be reliable.
 |  | § Adolescents in the 2010 NIS-Teen were born during January 1992-February 1998. Vaccination coverage estimates include only adolescents who had adequately complete provider-reported immunization records. National estimates do not include adolescents living in the U.S. Virgin Islands (i.e., St. Croix, St. Thomas, St. John, and Water Island) (n=231).
 |  | ¶ Based on family income and household size using US Bureau of Census poverty thresholds for 2009.
 |  | ** Reported by respondent. Adolescents identified as White, Black, American Indian/Alaska Native, Asian, or Native Hawaiian/Pacific Islander are all non-Hispanic. Adolescents of Hispanic ethnicity may be of any race.
 |  | ††  [NAME] 2 doses of measles-mumps-rubella vaccine
 |  | §§    ≥3 doses of hepatitis B vaccine.
 |  | ¶¶    [NAME] 1 dose of varicella vaccine among adolescents without a history of varicella disease.
 |  | ***   [NAME] 2 doses of varicella vaccine among adolescents without a history of varicella disease.
 |  | [NAME] 1 dose of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.
 |  | §§§ ≥ 1 dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.
 |  | ¶¶¶   ≥1  dose of meningococcal conjugate vaccine or meningococcal -unknown type vaccine.
 |  | ****  ≥1 dose of human papillomavirus vaccine, either quadrivalent or bivalent. Percentages reported among females only ([NAME]).
 |  | †††† Percent of females who received three doses among those who had at least one HPV dose and at least 24 weeks between the first dose and the interview date.